(Q36089872)

English

Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins (English)

1 reference

Europe PubMed Central

12 August 2017

1 reference

based on heuristic

inferred from title

pancreatic cyst

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Benjamin F Mann

1

1 reference

Europe PubMed Central

12 August 2017

John A Goetz

2

1 reference

Europe PubMed Central

12 August 2017

Michael G House

3

1 reference

Europe PubMed Central

12 August 2017

C Max Schmidt

4

1 reference

Europe PubMed Central

12 August 2017

Milos V Novotny

5

1 reference

Europe PubMed Central

12 August 2017

publication date

5 March 2012

1 reference

Europe PubMed Central

12 August 2017

Molecular & Cellular Proteomics

1 reference

Europe PubMed Central

12 August 2017

11

1 reference

Europe PubMed Central

12 August 2017

7

1 reference

Europe PubMed Central

12 August 2017

M111.015792

1 reference

Europe PubMed Central

12 August 2017

N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Serum biomarker panels for the detection of pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Software tool for researching annotations of proteins: open-source protein annotation software with data visualization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

A compendium of potential biomarkers of pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Proteomic analyses of pancreatic cyst fluids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Biological function of fucosylation in cancer biology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Classification of pancreatic cystic lesions using SELDI-TOF mass spectrometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Alterations in the serum glycome due to metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Practice guidelines in acute pancreatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Solid-phase permethylation of glycans for mass spectrometric analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Suppression of beta 1,3galactosyltransferase beta 3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly N-acetyllactosamines and sialyl-Lewis x on O-glycans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Tumor-associated trypsin inhibitor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Interactions of pancreatic secretory trypsin inhibitor in small intestinal juice: its hydrolysis and protection by intraluminal factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

2 October 2017

Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

11 July 2018

The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

11 July 2018

Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

11 July 2018

Carbohydrate structure of human pancreatic elastase 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

11 July 2018

Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Comparison of plasma Tu-M2-PK and CA19-9 in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Overexpression of sialyl Lewis x antigen is associated with formation of extratumoral venous invasion and predicts postoperative development of massive hepatic metastasis in cases with pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Clinical value of serum neopterin, tissue polypeptide-specific antigen and CA19-9 levels in differential diagnosis between pancreatic cancer and chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Application of proteomic technology in identifying pancreatic secretory trypsin inhibitor variants in urine of patients with pancreatitis

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Preoperative differential diagnosis of benign and malignant pancreatic lesions--the value of pancreatic secretory trypsin inhibitor, procarboxypeptidase B, CA19-9 and CEA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394951

23 September 2018

Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Prevalence of incidental pancreatic cysts in the adult population on MR imaging

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M111.015792

21 January 2018

Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of cystic pancreatic masses: relative accuracy of CT and MRI

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fucosylated type-2 chain polylactosamine antigens in human lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical assessment compared with cyst fluid analysis in the differential diagnosis of cystic lesions in the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1074/MCP.M111.015792

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36089872&oldid=1980407963"